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Abstract: N-cycloalkyl-substituted amino acids
have wide-ranging applications in pharma- and
nutraceutical fields. Here we report the asymmetric
synthesis of various N-cycloalkyl-substituted l-
aspartic acids using ethylenediamine-N,N’-disuc-
cinic acid lyase (EDDS lyase) and a previously
engineered variant of methylaspartate ammonia
lyase (MAL-Q73A) as biocatalysts. Particularly,
EDDS lyase shows broad non-natural substrate
promiscuity and excellent enantioselectivity, allow-
ing the selective addition of homo- and hetero-
cycloalkyl amines (comprising four-, five- and six-
membered rings) to fumarate, giving the corre-
sponding N-cycloalkyl-substituted l-aspartic acids
with >99% e.e. This biocatalytic methodology
offers an alternative synthetic choice to prepare
difficult N-cycloalkyl-substituted amino acids. Giv-
en its very broad amine scope, EDDS lyase is an
exceptionally powerful synthetic tool that nicely
complements the rapidly expanding toolbox of
biocatalysts for asymmetric synthesis of noncanon-
ical amino acids.
Keywords: Biocatalysis; Hydroamination; EDDS
lyase; Noncanonical amino acids
N-substituted L-aspartic acids are noncanonical amino
acids that have wide applications in pharma- and
nutraceutical fields, serving as drug candidates and
chiral building blocks for pharmaceutically active
molecules, artificial sweeteners and peptido-
mimetics.[1–7] Therefore, the development of method-
ologies for the efficient synthesis of N-substituted
aspartic acids in enantioenriched form is of high
academic and industrial interest. The most common
chemocatalytic synthetic strategy is the Michael
addition of suitable amines to maleic acid, fumaric
acid, their ester or amide derivatives, or monoalkali
salts.[7–9] However, in these chemocatalytic reactions,
racemic product mixtures are obtained. To achieve the
desired single L-enantiomer, purification or resolution
is needed, leading to unsatisfactory product yields
lower than 50%.
Asymmetric hydroamination of alkenes is a desir-
able atom-economic route to introduce nitrogen-based
functionalities into organic molecules.[10–12] Enzymatic
addition of ammonia or amines to appropriate α,β-
unsaturated mono- or dicarboxylic acids using C  N
lyases as biocatalysts has become an attractive method-
ology to synthesize chiral α-amino acids, such as
phenylalanine and aspartic acid, and their derivatives
(Scheme 1).[10,13–15] This enzymatic strategy employs
readily available α,β-unsaturated acids as starting
materials, escaping steps of protecting/activating car-
boxylic groups by derivatization as the corresponding
esters or amides, and normally gives high stereocontrol
under mild and potentially green reaction conditions.
Using this concept, a range of N-substituted L-aspartic
acids has previously been prepared.[16–18] For instance,
aspartate ammonia lyase (AspB) from Bacillus sp.
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YM55-1 and methylaspartate ammonia lyase (MAL)
from Clostridium tetanomorphum were found to accept
several small substituted amines, like hydroxylamine,
methoxylamine and methylamine, as substrates for
hydroamination of fumarate or mesaconate, yielding
the corresponding N-substituted L-aspartic acid
derivatives.[16,17] MAL is a homodimeric protein that
belongs to the enolase superfamily, and exploits a
deamination mechanism that involves general-base
catalyzed formation of an enolate anion (aci-carbox-
ylate) intermediate that is stabilized by coordination to
the essential active site Mg2+ ion.[14] The detailed
knowledge of the structure and catalytic mechanism of
MAL served as a guide to expand the synthetic
usefulness of this enzyme by protein engineering.[19]
Two variants of MAL were generated, one having an
enlarged nucleophile scope (MAL-Q73A) and the
other having an enlarged electrophile scope (MAL-
L384A).[19] Using MAL-Q73A, a large variety of N-
substituted L-aspartic acids were synthesized with high
enantioselectivity (>99% e.e.).[20] Structural analysis
of MAL-Q73A showed that this mutant enzyme has an
enlarged amine binding pocket, without changes in the
orientation of active site residues, thus rationalizing its
ability to convert the new amine substrates.[19]
Recently, we reported another C  N lyase, ethyl-
enediamine-N,N’-disuccinic acid (EDDS) lyase from
Chelativorans sp. BNC1, that can catalyze the rever-
sible addition of ethylene diamine to two molecules of
fumarate to produce (S,S)-EDDS, which is an attractive
biodegradable metal-chelator.[21] Wild-type EDDS
lyase has a large amine scope, including linear mono-
and diamines, and its preparative usefulness was
recently demonstrated in the chemoenzymatic syn-
thesis of aspergillomarasmine A (AMA), an important
metallo-β-lactamase inhibitor, as well as various
related aminocarboxylic acids.[22]
Cycles are versatile and important structural moi-
eties present in organic molecules, which act as good
modifiers of properties and biological activities.[23–26]
Functionalization of amino acids with cycles is a
subject of great interest, leading to a diversity of useful
noncanonical amino acids with broad applications.[27–29]
Here we report the asymmetric synthesis of various N-
cycloalkyl-substituted L-aspartic acids using MAL-
Q73A and EDDS lyase as biocatalysts. This biocata-
lytic methodology provides an alternative synthetic
choice to prepare difficult N-cycloalkyl-substituted
amino acids.
Previous work from our group demonstrated that
the Q73A mutant of MAL exhibits an expanded amine
scope, accepting various structurally distinct amines in
hydroamination reactions.[19,20] This prompted us to
first test the potential of MAL-Q73A for the asym-
metric synthesis of N-cycloalkyl-substituted L-aspartic
acids. Out of ten amines tested, MAL-Q73A only
accepted amines 2b, 2e and 2f as substrates (Table 1).
However, the observed conversions for the reactions
with cycloalkyl amines 2b, 2e and 2f were quite low
(20–25%). The enzymatic products 3b, 3e, and 3 f
were purified and identified as the corresponding N-
substituted aspartic acid derivatives by 1H NMR, 13C
NMR and HRMS (see Supporting Information).
As MAL-Q73A showed a narrow cycloalkyl amine
scope, we investigated the amine scope of EDDS lyase.
Remarkably, EDDS lyase accepted all ten amines as
substrates for addition to fumarate, giving high
conversions (83–99%) for most reactions (Table 1).
Relatively low conversions were observed for reactions
with homocycloalkyl amines 2b and 2e (25% and
10%, respectively) as well as with heterocycloalkyl
amines 2h and 2 i (14% and 46%, respectively). The
enzymatic products were isolated and identified as the
anticipated N-substituted aspartic acids by 1H NMR,
13C NMR and HRMS (see Supporting Information).
Hence, EDDS lyase shows a broad amine scope,
accepting structurally distinct homo- and heterocy-
cloalkyl amines in the hydroamination of fumarate.
The absolute configuration and optical purity of the
enzymatic products was determined by HPLC using a
chiral stationary phase. For this, N-substituted L-
aspartic acids and N-substituted D-aspartic acids were
prepared by chemical synthesis and used as authentic
standards (for detailed procedures, see Supporting
Information). The three products from the MAL-
Q73A-catalyzed hydroamination reactions (3b, 3e and
3f) were identified as the desired L-configured
enantiomers, with >99% enantiomeric excess (e.e.)
(Table 1, Figures S31, S34, S40). Analysis of eight
selected products from the EDDS-lyase-catalyzed
hydroamination reactions (3b–d, 3f–j) showed that the
absolute configuration of the newly formed stereogenic
center was L in all cases (>99% e.e., Table 1,
Figures S31–S39), while no D-configured enantiomers
were observed. With regard to amino acid products 3c
and 3d, pairs of diastereoisomers (S,S- and S,R-
configured) were formed from addition of racemic
mixtures of 2c and 2d to fumarate, and the diastereo-
meric ratio (d.r.) values were determined to be 50:50
(Figures S32 and S33). This revealed that EDDS lyase
accepts both enantiomers of the starting racemic
substrates 2c or 2d in the hydroamination reactions.
Scheme 1. Direct hydroamination of α,β-unsaturated carboxylic
acids catalyzed by a C  N lyase with enantiocontrol to
synthesize optically pure α-amino acids.
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Table 1. Enantioselective synthesis of N-cycloalkyl-substituted l-aspartic acids via addition of amines 2a–2j to fumarate catalyzed
by MAL-Q73A or EDDS lyase.








1 2a 3a 0 – 99 n.d.[e]
2 2b 3b 20 >99 25 >99
3[a] 2c 3c 0 – 89 >99/50:50[f]
4[a] 2d 3d 0 – 83 >99/50:50[f]
5 2e 3e 20 >99 10 n.d.
6 2f 3 f 25 >99 84 >99
7 2g 3g 0 – 91 >99
8 2h 3h 0 – 14 >99
9 2 i 3 i 0 – 46 >99
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Thus, both MAL-Q73A and EDDS lyase exhibit
excellent enantioselectivity in the addition of substi-
tuted amines to fumarate, yielding the desired optically
pure L-aspartic acid derivatives.
To further demonstrate the synthetic usefulness of
EDDS lyase, preparative-scale synthesis of amino acid
3f was performed. Accordingly, substrates 1 (10 mM)
and 2f (100 mM) were incubated with EDDS lyase
(0.15 mol%) in 20 mM NaH2PO4  NaOH buffer at
pH 8.5 and room temperature. Under these conditions,
excellent conversion (85%) and good isolated yield
(54%, 117 mg) of optically pure (>99% e.e.) product
3f were achieved.
In conclusion, we explored the substrate scope of
two C  N lyases, a previously engineered variant of
MAL (mutant Q73A)[14,19] and wild-type EDDS
lyase,[21,22] towards a series of homo- and heterocy-
cloalkyl amines. Pleasingly, EDDS lyase was found to
possess broad non-natural substrate promiscuity ac-
cepting various cycloalkyl amines in the hydroamina-
tion of fumarate. A set of N-cycloalkyl-substituted L-
aspartic acids was synthesized with excellent stereo-
selectivity (>99% e.e. for all amino acid products),
including those with interesting heterocyclic substitu-
ents that might allow ring opening and further
derivatization for various applications.[30–33] Previous
studies on EDDS lyase revealed that this C  N lyase,
when working in reverse, accepts a wide variety of
amino acids and diamines as substrates in the hydro-
amination of fumarate, giving rise to a large number of
useful aminocarboxylic acid products, including bio-
degradable metal chelators and potent metallo-β-
lactamase inhibitors.[21,22] Hence, EDDS lyase is a
powerful synthetic tool that nicely complements the
rapidly expanding toolbox of biocatalysts for asym-
metric synthesis of unnatural amino acids. In contrast
to its broad amine scope, EDDS lyase was found to be
specific for fumarate, and not capable to accept
fumaric acid monomethyl ester, crotonic acid, mesa-
conic acid, itaconic acid, 2-pentenoic acid or gluta-
conic acid as alternative substrate for
hydroamination.[21] Work is in progress to expand the
electrophile scope of EDDS lyase by structure-based
protein engineering.
Experimental Section
General procedure for enzymatic synthesis of N-cycloalkyl-
substituted aspartic acids. For a typical MAL-Q73A reaction,
an initial reaction mixture (15 ml) consisting of fumaric acid
(0.2 mmol, 200 ul of 1 M stock solution), an amine (2a–2 j;
2 mmol), and MgCl2 (0.4 mmol, 400 ul of 1 M stock solution)
was prepared in demineralized (demi) water and the pH was
adjusted to 9.0. MAL-Q73A (0.1 mol% based on fumaric acid)
was added to start the reaction, and the volume of the reaction
mixture was immediately adjusted to 20 ml with demi water.
Table 1. continued








10 2j 3 j 0 – 92 >99/>99:1[g]
[a] Substrates 2c and 2d were used as racemic mixtures.
[b] Reaction conditions: fumaric acid (1, 10 mM), amine 2a–j (100 mM), MgCl2 (20 mM), and MAL-Q73A (0.1 mol% based on
fumaric acid) in H2O at pH 9 and room temperature. Reactions were allowed to proceed for 5 d. Conversions were determined
using 1H NMR spectroscopy.
[c] The e.e. and d.r. values were determined by chiral HPLC analysis using chemically synthesized reference compounds with known
configuration.
[d] Reaction conditions: fumaric acid (1, 10 mM), amines 2a–j (100 mM) and EDDS lyase (0.15 mol% based on fumaric acid) in
buffer (20 mM NaH2PO4/NaOH, pH 8.5) at room temperature. Reactions were allowed to proceed for 7 d. Conversions were
determined using 1H NMR spectroscopy.
[e] The isolated amino acid product could be tentatively assigned the L configuration on the basis of analogy.
[f] Products 3c and 3d were mixtures of (S,S)- and (S,R)-isomers (Figures S32 and S33).
[g] The absolute configuration of product 3 j is assigned to be L-trans; Figure S39).
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The reaction was allowed to proceed for 5 d, and was stopped
by heating at 70 °C for 10 min. Reaction progress was
monitored by 1H NMR spectroscopy. The conversions were
determined by comparing the signals corresponding to fumaric
acid (6.5 ppm) and amino acid product.
For a typical EDDS lyase reaction, an initial reaction mixture
(15 ml) containing fumaric acid (0.2 mmol, 200 ul of 1 M stock
solution) and an amine (2a–2 j; 2 mmol) in NaH2PO4  NaOH
buffer (20 mM, pH 8.5) was prepared. The pH was adjusted to
8.5 with hydrochloric acid solution. To start the reaction, EDDS
lyase (0.15 mol% based on fumaric acid) was added, and the
final volume of the reaction mixture was immediately adjusted
to 20 ml with the same buffer. The reaction was allowed to
proceed for 7 d, and stopped by heating at 70 °C for 10 min.
The reaction progress was monitored using 1H NMR spectro-
scopy by comparing signals corresponding to fumaric acid
(6.5 ppm) and amino acid product.
Enzymatic products were purified by two steps of ion-exchange
chromatography.[20] The purified products were lyophilized and
their identity was determined by using 1H NMR, 13C NMR and
HRMS. The enantiomeric excess and absolute configuration of
the product was determined by HPLC analysis on a chiral
stationary phase.
Further experimental details and product characterization are
given in the Supporting Information.
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